Last Updated: Sep 30, 2016
- Bringing Blood-Based Molecular Testing to the Clinic.
Janku Filip, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 9 - EGFR gene copy number as a predictive/biomarker for patients with non-small-cell lung cancer receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis.
Zhang Xin, et al. Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2016 9 - Prognostic and Predictive Value of KRAS Mutation in NSCLC.
Yamamoto Satomi, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 10 (10) e128-9 - Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
Yamamoto Noboru, et al. International journal of clinical oncology 2016 9 - MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.
Liu Bo, et al. Oncotarget 2016 9 - A new functional IDH2 genetic variant is associated with the risk of lung cancer.
Li Jiangjiang, et al. Molecular carcinogenesis 2016 9 - Association of polymorphisms in Dickopff (DKK) gene towards modulating risk for lung cancer in north Indians.
Bahl Charu, et al. Future oncology (London, England) 2016 9 - Epidermal Growth Factor Receptor (EGFR) co-mutated advanced non-small cell lung cancer (NSCLC) and response to EGFR tyrosine kinase inhibitors (TKIs): A Brief Report.
Barnet Megan, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 9 - Appetite Loss as an Adverse Effect During Treatment with EGFR-TKIs in Elderly Patients with Non-small Cell Lung Cancer.
Inomata Minehiko, et al. Anticancer research 2016 9 (9) 4951-4 - Bronchial Stump Recurrence after Complete Resection of Lung Cancer: Effect of the Distance between the Tumor and Bronchial Resection Margin.
Gunluoglu Mehmet Zeki, et al. The Thoracic and cardiovascular surgeon 2016 9 - Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma.
Zhi Qiongjie, et al. Oncotarget 2016 8 - Comprehensive characterization of oncogenic drivers in Asian lung adenocarcinoma.
Li Shiyong, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 9 - Identification of TRPCs genetic variants that modify risk for lung cancer based on the pathway and two-stage study.
Zhang Zili, et al. Meta gene 2016 9 191-6 - Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
Kumari Ankita, et al. Molecular biology reports 2016 9 - Implications of Personal Genomic Testing for Health Behaviors: The Case of Smoking.
Olfson Emily et al. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2016 Jul
- Human (30)
- Pathogen (0)
- Human (3949)
- Pathogen (0)
- Human (64)
- Pathogen (0)
- Huamn (4)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario